A Personalized Approach to Obesity Treatment Addressing obesity requires individualized care. Dr. Katherine H. Saunders, an obesity expert and Co-Founder of Intellihealth, emphasizes the complexity of obesity and the need for tailored treatment plans. "Obesity is a complex, multifactorial, relapsing chronic disease," she notes. "There's no one-size-fits-all solution when it comes to the heterogeneous disease of obesity. We use all the tools in our armamentarium to provide the highest level of evidence-based obesity care." Join us in advocating for comprehensive coverage of anti-obesity medications. Together, we can make a difference in the lives of those battling obesity. Read the white paper here: https://lnkd.in/ecdnBZYE #HealthEquity #ObesityCare #PersonalizedMedicine
Currax Pharmaceuticals LLC
Pharmaceutical Manufacturing
Brentwood, Tennessee 7,695 followers
Tackling the #1 and #2 causes of preventable death in the United States.
About us
Currax Pharmaceuticals LLC is a patient-first pharmaceutical company focused on the number one and number two preventable deaths in the United States: smoking addiction and obesity. Currax is proud to celebrate being recognized as a 2023 Best Places to Work by Nashville Business Journal thanks to our talented and hard-working employees.
- Website
-
http://www.curraxpharma.com/
External link for Currax Pharmaceuticals LLC
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Brentwood, Tennessee
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Biotechnology and Biopharmaceuticals
Locations
-
Primary
155 Franklin Rd
Suite 450
Brentwood, Tennessee 37027, US
Employees at Currax Pharmaceuticals LLC
-
Pamela Appel
Medical Affairs Strategy and Engagement
-
Anthony Orrico
VP Operations
-
Roxanne Schwans
Chief Operating Officer | Business Development Exec. | Board Member | Market Access | Trade | Healthcare & Pharmaceutical | Specialty Pharmacy |…
-
Irvin Carlin
Growth Marketing | Telemedicine | Pharma | Performance Media | Analytics | PPC | SEO | CRO | Paid Social | Marketing Automation
Updates
-
Transforming the Narrative on Obesity Treatment Costs Sensationalized projections about Medicare costs for anti-obesity drugs often overlook critical factors. A recent study challenges these assumptions, offering a realistic perspective on the fiscal implications of AOM Medicare coverage. By applying alternative assumptions grounded in current marketing conditions and health economics literature, it demonstrates the potential for significant cost reductions. "After accounting for existing GLP-1 use for diabetes and other adjustments, 3.2% of beneficiaries will be prescribed an AOM specifically for obesity in a given year," noted our findings. "This analysis suggests Medicare spending levels between $1.9 and $2.7 billion per year on incremental AOM coverage, which equals 1.0% to 1.6% of forecasted Medicare prescription drug spending." Read more here: https://lnkd.in/ecdnBZYE #HealthcareCosts #ObesityResearch #MedicareCoverage
How Much Will Covering Anti-Obesity Drugs Cost Medicare? Accounting for Commonly Overlooked Effects
https://secretariat-intl.com
-
Equitable Obesity Treatment Coverage At Currax, it is our mission that individuals living with obesity deserve equitable access to medications that effectively treat their condition. Yet, unlike other disease states, obesity has been left behind in the realm of insurance coverage for FDA-approved treatment options. As Congress contemplates the impactful Treat and Reduce Obesity Act (TROA), it's crucial that the financial analysis accurately reflects the landscape of anti-obesity medication (AOM) costs and treatments. A groundbreaking paper published by Intensity, a distinguished economic, finance, and data science firm, shows there is an affordable path to obesity treatment coverage. The paper was funded by Currax. The findings of this study are detailed in the paper, "How much will covering anti-obesity drugs cost Medicare? Accounting for commonly overlooked effects". Read the full publication here: https://lnkd.in/exaN_bJP #HealthcareCosts #ObesityResearch #MedicareCoverage
-
New reserach has been found on how the gut microbiome influences obesity onset differently in men and women. New findings, to be presented at this year's European Congress on Obesity (ECO) in Venice, Italy (12-15 May), shed light on changes in gut bacteria composition that play a pivotal role in obesity development. With differences observed between men and women, these insights could impact the metabolism of various nutrients and the presence of bioactive molecules in the gut, influencing the development of metabolic diseases. Read more about this groundbreaking research on News Medical: https://lnkd.in/eYZ62A7v
How gut microbiome influences obesity onset differently in men and women
news-medical.net
-
Obesity is a global epidemic and a house bill pushes national anti-obesity program in the Philippines. Muntinlupa City Rep. Jaime Fresnedi has introduced a bill proposing a comprehensive national program to manage and combat obesity among Filipinos. In House Bill No. 10162, titled the “National Integrated Obesity Management” measure, Fresnedi highlights the significant burden of obesity on the country's healthcare system. With obesity-associated illnesses like diabetes and cardiovascular diseases on the rise, this initiative aims to alleviate the strain on healthcare resources and promote healthier lifestyles. Read more about the proposed national anti-obesity program here: https://lnkd.in/eDFF5EHg **Currax Pharmaceuticals LLC does not condone negative images of patients with obesity. Photo credit to newsinfo.inquirier.net** #ObesityEpidemic #NationalAntiObesityProgram #PhilippinesHealthcare #ObesityManagement #PublicHealthInitiative #HealthcareLegislation
House bill pushes national anti-obesity program
https://newsinfo.inquirer.net
-
Currax recently celebrated our five-year milestone, marking a journey filled with growth and accomplishments! As we commemorate this milestone, we reaffirm our commitment to addressing the #1 and #2 causes of preventable death in the United States: smoking and obesity. At Currax, putting patients first and ensuring access to innovative treatments remain at the core of everything we do. #CurraxAnniversary #FiveYearMilestone #PreventableDeath #ObesityAwareness #PatientCare#HealthcareInnovation #HealthcareLeadership
-
Currax upholds the highest standards for field team excellence, people development, and determination. We are proud to introduce a program designed specifically for emerging leaders. This initiative cultivates core leadership capabilities and asseses proficiency for future leadership roles. Meet the emerging leaders of the Currax Training and Leadership Team: Derek Bornhorst, Dane Clemens, Alex Daniele, Lisa Dreher, Heather Gorton, Jamie Helms, Steven Jenny, Kendra Phillips, Nicole Rainey, Brian Rigney, Trent Spurrier, and Scott Steres have all completed this rigorous program and sharpened their leadership skills. Read more here: https://bit.ly/3wC2pds #LeadershipDevelopment #EmergingLeaders #TrainingExcellence #LeadershipSkills #PharmaLeadership #PeopleDevelopment #CurraxTeam #FieldExcellence #LeadershipAssessment
Cover Story: Currax Pharmaceuticals: Developing Emerging Leaders
read.nxtbook.com
-
Obesity stands as a significant contributor to healthcare burdens globally, heightening the risk of comorbidities like hypertension and diabetes. Clear, accessible, and consistent guidelines for diagnosis and management are essential for healthcare practitioners to effectively address this issue. Read these Q&A's from Physician's Weekly to gain insights into navigating the complexities of obesity management guidelines and optimizing patient care. https://bit.ly/3UQTApq #ObesityAwareness #Hypertension #Diabetes #Guidelines #PatientCare #PhysiciansWeekly
Q&A: Confronting Guideline Inconsistencies for Obesity Management
https://www.physiciansweekly.com
-
A weight-loss journey results in not just physical changes but also profound emotional effects. Experts shed light on what to expect and when to seek mental health support. A dramatic weight loss is a major change that happens to one’s body and, given the fact that our mind-body connection is so strong, physical changes will inevitably cause psychological changes as well," shared Kate Miskevics, LMFT, a therapist at LifeStance Health, with Healthline. Read more about the emotional impacts of weight loss: https://bit.ly/4bsVkdY #obesityisadisease #mentalhealthawareness #treatmentoptions
Ozempic: How Dramatic Weight Loss Can Affect You Emotionally
healthline.com
-
The Women’s Health Research briefing in DC was an impactful event and Currax representatives were glad to be part of the discussion. Obesity's impact on women and the crucial role of policy in enhancing outcomes was explored. Obesity is a pressing public health concern in the U.S., with far-reaching effects on millions with female patients bearing a disproportionate burden. Women face unique health challenges and economic costs, often compounded for marginalized communities. Panelists delved into the complexities of obesity's impact on women, highlighting unique risk factors, and the potential for federal policies to drive positive change. If you've missed the event, you can listen to the recording online here: https://lnkd.in/gQrs69AJ" #patientaccess #womenshealth #obesitymatters
Exploring Obesity’s Impact on Women and Policy’s Role in Improving Outcomes - Society for Women's Health Research
https://swhr.org